{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:33:43Z","timestamp":1787762023436,"version":"build-2784847793"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,10]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>The study aims to estimate the differences in vaginal surface, bladder, and rectal doses when adjuvant intracavitary brachytherapy is carried out with ovoids or with vaginal cylinders, in postoperative carcinoma endometrium and to assess the difference in variability in organs at risk (OAR) doses and thereby the reproducibility of application in subsequent sittings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>\n                      Fifteen patients each received vaginal brachytherapy with ovoid and cylindrical applicators. The dose received by 0.1 cc, 1.0 cc, 2.0 cc, 5.0 cc, and 10.0 cc volumes of the OAR, namely, bladder, and rectum were analyzed using independent\n                      <jats:italic toggle=\"yes\">t<\/jats:italic>\n                      -test. Interfractional variation in dose to OAR was evaluated using a two-way repeated ANOVA test. The dose received by the upper 2 cm of vagina was assessed using volume receiving 100% (V\n                      <jats:sub>100<\/jats:sub>\n                      ) and dose received by 100% (D\n                      <jats:sub>100<\/jats:sub>\n                      ) for documenting dose distribution to the target volume.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The mean dose to rectum and bladder were significantly lesser with ovoids (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.0001). This difference was seen in all volumes analyzed. V\n                      <jats:sub>100<\/jats:sub>\n                      (99.05% vs. 67.7%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.0001) and D\n                      <jats:sub>100<\/jats:sub>\n                      (95.70% vs. 53.08%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.0001) were significantly better with cylinders compared to ovoids. There was no statistically significant interfractional variation between sittings with either applicator.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The two applicators studied have different dosimetric properties conferring specific advantages and disadvantages as far as dose to OARs and target is concerned. Both applicators provide good reproducibility. The choice of applicator would ultimately depend on the clinical outcomes of these dosimetric differences which need to be prospectively analyzed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_471_17","type":"journal-article","created":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T07:56:32Z","timestamp":1524729392000},"page":"1191-1195","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Dosimetric comparison of bladder, rectal, and vaginal surface doses between ovoids and cylinder-based vaginal brachytherapy in carcinoma of the endometrium"],"prefix":"10.4103","volume":"14","author":[{"given":"Naveen Pradeep","family":"Kumar","sequence":"first","affiliation":[{"name":"Division of Radiation Oncology, Regional Cancer Centre, Thiruvananthapuram, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aswin","family":"Kumar","sequence":"additional","affiliation":[{"name":"Division of Radiation Oncology, Regional Cancer Centre, Thiruvananthapuram, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puthuveettil G.","family":"Jayaprakash","sequence":"additional","affiliation":[{"name":"Division of Radiation Oncology, Regional Cancer Centre, Thiruvananthapuram, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Raghukumar","sequence":"additional","affiliation":[{"name":"Division of Radiation Physics, Regional Cancer Centre, Thiruvananthapuram, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis V.","family":"James","sequence":"additional","affiliation":[{"name":"Division of Radiation Oncology, Regional Cancer Centre, Thiruvananthapuram, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2018,11,28]]},"reference":[{"key":"R1-20260109","author":"Ferlay","year":"2013","journal-title":"GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11"},{"key":"R2-20260109","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/1097-0142(19911115)68:10<2293::AID-CNCR2820681032>3.0.CO;2-V","article-title":"The significance of squamous differentiation in endometrial carcinoma. Data from a Gynecologic Oncology Group Study","volume":"68","author":"Zaino","year":"1991","journal-title":"Cancer"},{"key":"R3-20260109","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/cncr.2820710410","article-title":"Virulence factors in endometrial cancer","volume":"71","author":"Gusberg","year":"1993","journal-title":"Cancer"},{"key":"R4-20260109","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/AOG.0b013e3182605bf1","article-title":"Endometrial cancer","volume":"120","author":"Sorosky","year":"2012","journal-title":"Obstet Gynecol"},{"key":"R5-20260109","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0140-6736(08)61767-5","article-title":"Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): Pooled trial results, systematic review, and meta-analysis","volume":"373","author":"Blake","year":"2009","journal-title":"Lancet"},{"key":"R6-20260109","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":"Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: Multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma","volume":"355","author":"Creutzberg","year":"2000","journal-title":"Lancet"},{"key":"R7-20260109","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/IGC.0b013e3181a6c9df","article-title":"Intravaginal brachytherapy in FIGO stage I low-risk endometrial cancer: A controlled randomized study","volume":"19","author":"Sorbe","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"R8-20260109","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ijrobp.2014.11.022","article-title":"Nomograms for prediction of outcome with or without adjuvant radiation therapy for patients with endometrial cancer: A pooled analysis of PORTEC-1 and PORTEC-2 trials","volume":"91","author":"Creutzberg","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R9-20260109","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/bjc.2015.35","article-title":"Just how accurate are the major risk stratification systems for early-stage endometrial cancer","volume":"112","author":"Bendifallah","year":"2015","journal-title":"Br J Cancer"},{"key":"R10-20260109","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: A Gynecologic Oncology Group study","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol Oncol"},{"key":"R11-20260109","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): An open-label, non-inferiority, randomised trial","volume":"375","author":"Nout","year":"2010","journal-title":"Lancet"},{"key":"R12-20260109","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/S0360-3016(01)01765-5","article-title":"The morbidity of treatment for patients with stage I endometrial cancer: Results from a randomized trial","volume":"51","author":"Creutzberg","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R13-20260109","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/S0360-3016(03)00414-0","article-title":"Definitive radiotherapy for patients with isolated vaginal recurrence of endometrial carcinoma after hysterectomy","volume":"56","author":"Jhingran","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R14-20260109","doi-asserted-by":"crossref","first-page":"e631","DOI":"10.1016\/j.ijrobp.2011.04.013","article-title":"Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma","volume":"81","author":"Creutzberg","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R15-20260109","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0360-3016(00)00689-1","article-title":"The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the endometrium","volume":"48","author":"Nag","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R16-20260109","doi-asserted-by":"crossref","first-page":"e353","DOI":"10.1016\/j.ijrobp.2012.01.023","article-title":"Pelvic normal tissue contouring guidelines for radiation therapy: A Radiation Therapy Oncology Group consensus panel atlas","volume":"83","author":"Gay","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R17-20260109","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.ijrobp.2013.06.083","article-title":"Vaginal dose and toxicity with image-guided brachytherapy","volume":"2","author":"Chino","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R18-20260109","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0167-8140(98)80087-X","article-title":"Influence of applicator shape on the dose to rectum and bladder in vaginal cuff brachytherapy","volume":"47","author":"Zingoni","year":"1998","journal-title":"Radiother Oncol"},{"key":"R19-20260109","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S1538-4721(02)00051-X","article-title":"Postoperative intravaginal brachytherapy for endometrial cancer; dosimetric analysis of vaginal colpostats and cylinder applicators","volume":"1","author":"Kim","year":"2002","journal-title":"Brachytherapy"},{"key":"R20-20260109","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.ijrobp.2003.11.039","article-title":"Geometric and dosimetric variations of ICRU bladder and rectum reference points in vaginal cuff brachytherapy using ovoids","volume":"58","author":"Garipagaoglu","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01363817-201814060-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:11:49Z","timestamp":1787760709000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01363817-201814060-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_471_17","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10]]}}}